Inhibition of voltage-gated potassium channels affect expressions of miR-126 and miR-126*in breast cancer cell lines

被引:3
|
作者
Cosan, Turgut D. [1 ]
Soyocak, A. [2 ]
Oner, C. [3 ]
机构
[1] Eskisehir Osmangazi Univ, Med Fac, Dept Med Biol, Eskisehir, Turkey
[2] Istanbul Aydin Univ, Med Fac, Dept Med Biol & Genet, Istanbul, Turkey
[3] Maltepe Univ, Med Fac, Dept Med Biol & Genet, Istanbul, Turkey
来源
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY | 2020年 / 121卷 / 02期
关键词
breast cancer; Kv1.3; Kv10.1; miR-126; miR-126*; INDUCED APOPTOSIS; KV1.3; CHANNELS; ION CHANNELS; PROLIFERATION; MICRORNAS; ETHER; LYMPHOCYTE; RESISTANCE; MIGRATION; ONCOGENE;
D O I
10.4149/BLL_2020_014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AIM: We aimed to determine the possible correlation between voltage-gated potassium channels and micro RNAs in breast cancer and metastatic breast cancer cells. METHOD: Kv1.3 and Kv10.1 channels were inhibited by specific siRNAs using a lipofectamine-based transfection in MCF-7 and MDA-MB-231 cells. After transfection, total RNA was isolated, and then miR-126 and miR-126* expressions were observed using RT-PCR. RESULTS: There was a negative correlation between Kv channels and miRNAs according to the characteristics of the breast cancer cells. The inhibition was observed not only in Kv1.3 but also in Kv10.1 in MCF-7 cells, and miR-126 and miR-126* expressions were downregulated compared to the control group (p < 0.001). The inhibition of these channels in MDA-MB-231 cells caused an upregulation of miR-126 and miR-126* expressions (p < 0.001). CONCLUSION: The miR-126 and miR-126* expressions differed according to benign and malign breast cancer cell lines. Furthermore, we found that miR-126/126* may interact with Kv1.3 and Kv10.1 voltage-gated potassium channels. Our study suggests and indicates the relationship between Kv channels and miRNAs in breast cancer cells.
引用
收藏
页码:111 / 116
页数:6
相关论文
共 50 条
  • [1] miR-126 and miR-126*repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis
    Zhang, Yun
    Yang, Pengyuan
    Sun, Tao
    Li, Dong
    Xu, Xin
    Rui, Yaocheng
    Li, Chaoran
    Chong, Mengyang
    Ibrahim, Toni
    Mercatali, Laura
    Amadori, Dino
    Lu, Xincheng
    Xie, Dong
    Li, Qi-Jing
    Wang, Xiao-Fan
    NATURE CELL BIOLOGY, 2013, 15 (03) : 284 - 294
  • [2] Prognostic Value and Biological Role of miR-126 in Breast Cancer
    Soofiyani, Saiedeh Razi
    Hosseini, Kamran
    Ebrahimi, Tahereh
    Forouhandeh, Haleh
    Sadeghi, Mohammadreza
    Beirami, Sohrab Minaei
    Ghasemnejad, Tohid
    Tarhriz, Vahideh
    Montazersaheb, Soheila
    MICRORNA, 2022, 11 (02) : 95 - 103
  • [3] miR-126 regulated breast cancer cell invasion by targeting ADAM9
    Wang, Cheng-Zheng
    Yuan, Peng
    Li, Yin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (06): : 6547 - 6553
  • [4] Expression and correlation of miR-124 and miR-126 in breast cancer
    Li, Fanfan
    ONCOLOGY LETTERS, 2019, 17 (06) : 5115 - 5119
  • [5] The inhibition of miR-126 in cell migration and invasion of cervical cancer through regulating ZEB1
    Xu, Jiqin
    Wang, Hongyun
    Wang, Huiyan
    Chen, Qing
    Zhang, Li
    Song, Chao
    Zhou, Qianqian
    Hong, Ying
    HEREDITAS, 2019, 156 (1)
  • [6] miR-126 functions as a tumour suppressor in human gastric cancer
    Feng, Runhua
    Chen, Xuehua
    Yu, Yingyan
    Su, Liping
    Yu, Beiqin
    Li, Jianfang
    Cai, Qu
    Yan, Min
    Liu, Bingya
    Zhu, Zhenggang
    CANCER LETTERS, 2010, 298 (01) : 50 - 63
  • [7] MiR-126 promotes esophageal squamous cell carcinoma via inhibition of apoptosis and autophagy
    Li, Mingli
    Meng, Xiangli
    Li, Mingxuan
    AGING-US, 2020, 12 (12): : 12107 - 12118
  • [8] Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk
    Yang, Rongxi
    Dick, Michelle
    Marme, Frederik
    Schneeweiss, Andreas
    Langheinz, Anne
    Hemminki, Kari
    Sutter, Christian
    Bugert, Peter
    Wappenschmidt, Barbara
    Varon, Raymonda
    Schott, Sarah
    Weber, Bernhard H. F.
    Niederacher, Dieter
    Arnold, Norbert
    Meindl, Alfons
    Bartram, Claus R.
    Schmutzler, Rita K.
    Mueller, Heiko
    Arndt, Volker
    Brenner, Hermann
    Sohn, Christof
    Burwinkel, Barbara
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (02) : 549 - 554
  • [9] miR-107 and miR-126 and Risk of Breast Cancer: A Case-Control Study
    Gupta, Priyanka
    Sambyal, Vasudha
    Bali, Jagmohan Singh
    Guleria, Kamlesh
    Uppal, Manjit Singh
    Sudan, Meena
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2024, 28 (04) : 165 - 168
  • [10] Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk
    Rongxi Yang
    Michelle Dick
    Frederik Marme
    Andreas Schneeweiss
    Anne Langheinz
    Kari Hemminki
    Christian Sutter
    Peter Bugert
    Barbara Wappenschmidt
    Raymonda Varon
    Sarah Schott
    Bernhard H. F. Weber
    Dieter Niederacher
    Norbert Arnold
    Alfons Meindl
    Claus R. Bartram
    Rita K. Schmutzler
    Heiko Müller
    Volker Arndt
    Hermann Brenner
    Christof Sohn
    Barbara Burwinkel
    Breast Cancer Research and Treatment, 2011, 127 : 549 - 554